Business Context and Reporting Period
This Form 8-K Current Report was filed by Rockwell Medical, Inc. (RMTI) on November 17, 2025. The filing addresses corporate governance changes under Item 5.02, specifically the departure of a director and the appointment of a new director to the Board.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on personnel changes and associated compensation arrangements.
Material Changes
- Director Resignation: Andrea Heslin Smiley resigned from the Board of Directors and all committees effective immediately on November 17, 2025. The resignation was not due to any disagreement with the Company.
- Director Appointment: Joseph H. Dawson was appointed as a Class II director effective immediately, serving until the 2026 Annual Meeting of Stockholders. He was also appointed to the Nominating and Corporate Governance Committee.
- Compensation Arrangements: Mr. Dawson's compensation includes an annual cash retainer of $45,000 (pro-rated) and a $5,000 committee retainer. He received an option to purchase 25,000 shares and 25,000 restricted stock units (RSUs), vesting on November 17, 2026.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future business performance. No specific risks or contingencies related to the company's operations were disclosed in this report. The appointment of Mr. Dawson, a former President of North America for Nipro Medical Corporation, suggests a strategic focus on leveraging his medical device industry experience.
Key Facts for Investor Verification
- Verify the impact of the Board composition change on the Company's strategic direction.
- Confirm the vesting schedule and exercise price of the 25,000 stock options granted to Mr. Dawson.
- Review the Company's 2026 Annual Meeting proxy statement for details on the election of Mr. Dawson as a Class II director.
- Check subsequent filings for any financial updates, as this 8-K contains no financial data.